FDA launches new AI-powered system to track drug and vaccine side effects in real time, replacing outdated databases and saving $120 million annually.

The FDA has launched a new adverse event reporting system that will consolidate several systems it has for reporting different types of adverse events, the agency announced Wednesday. The new system, ...

Yesterday, the Food and Drug Administration (FDA) announced the launch of the Adverse Event Monitoring System ( AEMS ), a new platform for assessing adverse event reports made to the FDA for drugs, ...

March 11 (Reuters) - The U.S. Food and Drug Administration said on Wednesday it has introduced a unified platform designed to ...

FDA replaces seven fragmented adverse event databases with AEMS, enabling real-time safety signal access for pharmaceutical manufacturers and researchers. On March 11, the FDA launched a unified ...

FDA launches single adverse event platform to consolidate drug, vaccine, and device reports, improving transparency and saving $120 million annually.

With former director of the FDA’s Center for Biologics Evaluation and Research Peter Marks, M.D., Ph.D., out of the picture, HHS secretary Robert F. Kennedy Jr. (RFK Jr.) appears to be setting his ...

DEAR DR. ROACH: You recently posted a couple of articles about the respiratory syncytial virus (RSV) vaccine and the benefits versus the risks. I know the risks are based on data. But I wonder how ...

Robert Moffit, Ph.D., is a senior research fellow in the Center for Health and Welfare Policy at The Heritage Foundation. This is the final piece in an eight-article series on “Restoring Trust in ...

There’s no way of knowing if anyone believed Dr. James Laidler back in 2004 when he reported that a flu vaccine had turned him into the Incredible Hulk. The symptoms he described certainly fit—green ...